{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T03:26:58Z","timestamp":1792985218110,"version":"4.5.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.lpm.2021.104063","type":"journal-article","created":{"date-parts":[[2021,2,5]],"date-time":"2021-02-05T07:03:52Z","timestamp":1612508632000},"page":"104063","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Scleroderma renal crisis"],"prefix":"10.1016","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6718-2468","authenticated-orcid":false,"given":"Marie","family":"Hudson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cybele","family":"Ghossein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Steen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.lpm.2021.104063_bib0280","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.semarthrit.2013.09.008","article-title":"Exposure to ACE inhibitors prior to the onset of scleroderma renal crisis-results from the International Scleroderma Renal Crisis Survey","volume":"43","author":"Hudson","year":"2014","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.lpm.2021.104063_bib0285","first-page":"649","article-title":"Kidney disease other than renal crisis in patients with diffuse scleroderma","volume":"32","author":"Steen","year":"2005","journal-title":"J Rheumatol"},{"issue":"9","key":"10.1016\/j.lpm.2021.104063_bib0290","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.3899\/jrheum.111417","article-title":"Longitudinal study of renal function in systemic sclerosis","volume":"39","author":"Caron","year":"2012","journal-title":"J Rheumatol"},{"issue":"5","key":"10.1016\/j.lpm.2021.104063_bib0295","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/0002-9343(84)90986-0","article-title":"Factors predicting development of renal involvement in progressive systemic sclerosis","volume":"76","author":"Steen","year":"1984","journal-title":"Am J Med"},{"issue":"10","key":"10.1016\/j.lpm.2021.104063_bib0300","doi-asserted-by":"crossref","first-page":"e0163894","DOI":"10.1371\/journal.pone.0163894","article-title":"Incidences and Risk Factors of Organ Manifestations in the Early Course of Systemic Sclerosis: A Longitudinal EUSTAR Study","volume":"11","author":"Jaeger","year":"2016","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.lpm.2021.104063_bib0305","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3899\/jrheum.180582","article-title":"Scleroderma Renal Crisis: Risk Factors for an Increasingly Rare Organ Complication","volume":"47","author":"Moinzadeh","year":"2020","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.lpm.2021.104063_bib0310","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s13075-020-2141-2","article-title":"ACE inhibitors in SSc patients display a risk factor for scleroderma renal crisis-a EUSTAR analysis","volume":"22","author":"Butikofer","year":"2020","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"10.1016\/j.lpm.2021.104063_bib0315","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1002\/art.38390","article-title":"Prediction of pulmonary complications and long-term survival in systemic sclerosis","volume":"66","author":"Nihtyanova","year":"2014","journal-title":"Arthritis Rheumatol"},{"issue":"51","key":"10.1016\/j.lpm.2021.104063_bib0320","doi-asserted-by":"crossref","first-page":"e8980","DOI":"10.1097\/MD.0000000000008980","article-title":"Medsger TA, Jr., Steen VD, et al. Clinical and serological features of systemic sclerosis in a multicenter African American cohort: Analysis of the genome research in African American scleroderma patients clinical database","volume":"96","author":"Morgan","year":"2017","journal-title":"Medicine (Baltimore)."},{"issue":"4","key":"10.1016\/j.lpm.2021.104063_bib0325","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1002\/art.38994","article-title":"Clinical and immunologic predictors of scleroderma renal crisis in Japanese systemic sclerosis patients with anti-RNA polymerase III autoantibodies","volume":"67","author":"Hamaguchi","year":"2015","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"10.1016\/j.lpm.2021.104063_bib0330","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/art.38219","article-title":"Prevalence of anti-RNA polymerase III antibodies in systemic sclerosis: New data from a French cohort and a systematic review and meta-analysis","volume":"66","author":"Sobanski","year":"2014","journal-title":"Arthritis Rheumatol"},{"issue":"4","key":"10.1016\/j.lpm.2021.104063_bib0335","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1002\/art.39490","article-title":"Derivation and External Validation of a Prediction Rule for Five-Year Mortality in Patients With Early Diffuse Cutaneous Systemic Sclerosis","volume":"68","author":"Domsic","year":"2016","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"10.1016\/j.lpm.2021.104063_bib0340","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3899\/jrheum.171186","article-title":"Risk factors for future scleroderma renal crisis at systemic sclerosis diagnosis","volume":"46","author":"Gordon","year":"2019","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.lpm.2021.104063_bib0345","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/rheumatology\/keg023","article-title":"Calculated glomerular filtration rate is a useful screening tool to identify scleroderma patients with renal impairment","volume":"42","author":"Kingdon","year":"2003","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"10.1016\/j.lpm.2021.104063_bib0350","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1002\/1529-0131(199809)41:9<1613::AID-ART11>3.0.CO;2-O","article-title":"Medsger TA, Jr. Case-control study of corticosteroids and other drugs that either precipitate or protect from the development of scleroderma renal crisis","volume":"41","author":"Steen","year":"1998","journal-title":"Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.lpm.2021.104063_bib0355","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1002\/art.10589","article-title":"Predictors and outcomes of scleroderma renal crisis: the high-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial","volume":"46","author":"DeMarco","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.lpm.2021.104063_bib0360","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s00296-010-1697-6","article-title":"Corticosteroids and the risk of scleroderma renal crisis: a systematic review","volume":"32","author":"Trang","year":"2012","journal-title":"Rheumatol Int"},{"issue":"7","key":"10.1016\/j.lpm.2021.104063_bib0365","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1136\/ard.2006.066068","article-title":"Medsger TA. Changes in causes of death in systemic sclerosis, 1972\u20132002","volume":"66","author":"Steen","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.lpm.2021.104063_bib0370","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1002\/art.40027","article-title":"Early Mortality in a Multinational Systemic Sclerosis Inception Cohort","volume":"69","author":"Hao","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.lpm.2021.104063_bib0375","article-title":"The Changing Mortality and Morbidity of Systemic Sclerosis: 1970\u20132016","author":"Kim","year":"2020","journal-title":"J Scleroderma Relat Disord [online first]"},{"issue":"4","key":"10.1016\/j.lpm.2021.104063_bib0380","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.autrev.2017.02.012","article-title":"Scleroderma Clinical Trials Consortium Scleroderma Renal Crisis Working Group Investigators of the Scleroderma Clinical Trials Consortium Scleroderma Renal Crisis Working G. Towards developing criteria for scleroderma renal crisis: A scoping review","volume":"16","author":"Hoa","year":"2017","journal-title":"Autoimmun Rev"},{"issue":"6","key":"10.1016\/j.lpm.2021.104063_bib0385","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/art.40809","article-title":"Generation of a core set of items to develop classification criteria for Scleroderma renal crisis using consensus methodology","volume":"71","author":"Butler","year":"2019","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"10.1016\/j.lpm.2021.104063_bib0390","first-page":"1","article-title":"Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO Clinical Practice Guideline for Acute Kidney Injury","volume":"2","author":"Kellum","year":"2012","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.lpm.2021.104063_bib0395","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1053\/j.ajkd.2016.02.033","article-title":"AJKD Atlas of Renal Pathology: Systemic Sclerosis","volume":"67","author":"Lusco","year":"2016","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1016\/j.lpm.2021.104063_bib0400","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0889-857X(03)00016-4","article-title":"Scleroderma renal crisis","volume":"29","author":"Steen","year":"2003","journal-title":"Rheum Dis Clin North Am"},{"issue":"1","key":"10.1016\/j.lpm.2021.104063_bib0405","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/art.1780370110","article-title":"Abnormalities of renal physiology in systemic sclerosis. A prospective study with 10-year followup","volume":"37","author":"Clements","year":"1994","journal-title":"Arthritis Rheum"},{"issue":"10","key":"10.1016\/j.lpm.2021.104063_bib0410","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1093\/rheumatology\/kep215","article-title":"A longitudinal study of anti-RNA polymerase III antibody levels in systemic sclerosis","volume":"48","author":"Nihtyanova","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.lpm.2021.104063_bib0415","first-page":"1","article-title":"Pathogenic roles of autoantibodies in systemic sclerosis: Current understandings in pathogenesis","author":"Sen\u00e9cal","year":"2019","journal-title":"J Scleroderma Related Disord"},{"issue":"1","key":"10.1016\/j.lpm.2021.104063_bib0420","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005792-197401000-00001","article-title":"The relationship of hypertension and renal failure in scleroderma (progressive systemic sclerosis) to structural and functional abnormalities of the renal cortical circulation","volume":"53","author":"Cannon","year":"1974","journal-title":"Medicine (Baltimore)"},{"issue":"9","key":"10.1016\/j.lpm.2021.104063_bib0425","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1093\/qjmed\/hct111","article-title":"Targeting the endothelin axis in scleroderma renal crisis: rationale and feasibility","volume":"106","author":"Penn","year":"2013","journal-title":"QJM"},{"issue":"3","key":"10.1016\/j.lpm.2021.104063_bib0430","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.humpath.2008.08.001","article-title":"Renal biopsy findings predicting outcome in scleroderma renal crisis","volume":"40","author":"Batal","year":"2009","journal-title":"Hum Pathol"},{"issue":"1","key":"10.1016\/j.lpm.2021.104063_bib0435","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1186\/s13075-016-1168-x","article-title":"Analysis of complement biomarkers in systemic sclerosis indicates a distinct pattern in scleroderma renal crisis","volume":"18","author":"Okroj","year":"2016","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"10.1016\/j.lpm.2021.104063_bib0440","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1002\/art.30111","article-title":"HLA-DRB1*0407 and *1304 are risk factors for scleroderma renal crisis","volume":"63","author":"Nguyen","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2021.104063_bib0445","doi-asserted-by":"crossref","DOI":"10.3899\/jrheum.190945","article-title":"Analysis of anti-RNA polymerase III antibody positive systemic sclerosis suggests altered GPATCH2L and CTNND2 expression in scleroderma renal crisis","author":"Stern","year":"2020","journal-title":"J Rheumatol"},{"issue":"12","key":"10.1016\/j.lpm.2021.104063_bib0450","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1056\/NEJMoa067655","article-title":"A polymorphism in the CTGF promoter region associated with systemic sclerosis","volume":"357","author":"Fonseca","year":"2007","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.lpm.2021.104063_bib0455","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3899\/jrheum.080622","article-title":"Angiotensin-converting enzyme gene does not contribute to genetic susceptibility to systemic sclerosis in European Caucasians","volume":"36","author":"Wipff","year":"2009","journal-title":"J Rheumatol"},{"issue":"8","key":"10.1016\/j.lpm.2021.104063_bib0460","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1093\/qjmed\/hcm052","article-title":"Scleroderma renal crisis: patient characteristics and long-term outcomes","volume":"100","author":"Penn","year":"2007","journal-title":"QJM"},{"issue":"11","key":"10.1016\/j.lpm.2021.104063_bib0465","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1002\/art.40560","article-title":"Treatment Algorithms for Systemic Sclerosis According to Experts","volume":"70","author":"Fernandez-Codina","year":"2018","journal-title":"Arthritis Rheumatol"},{"issue":"5","key":"10.1016\/j.lpm.2021.104063_bib0470","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1053\/j.ajkd.2005.01.007","article-title":"Late recurrence of scleroderma renal crisis in a renal transplant recipient despite angiotensin II blockade","volume":"45","author":"Cheung","year":"2005","journal-title":"Am J Kidney Dis"},{"issue":"suppl 10","key":"10.1016\/j.lpm.2021.104063_bib0475","article-title":"Bosentan in Scleroderma Renal Crisis: A National Open Label Prospective Study [abtract]","volume":"69","author":"B\u00e9rezn\u00e9","year":"2017","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"10.1016\/j.lpm.2021.104063_bib0480","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1093\/ckj\/sfv101","article-title":"Eculizumab for rescue of thrombotic microangiopathy in PM-Scl antibody-positive autoimmune overlap syndrome","volume":"8","author":"Thomas","year":"2015","journal-title":"Clin Kidney J"},{"issue":"30","key":"10.1016\/j.lpm.2021.104063_bib0485","doi-asserted-by":"crossref","first-page":"e4459","DOI":"10.1097\/MD.0000000000004459","article-title":"Complement activation and effect of eculizumab in scleroderma renal crisis","volume":"95","author":"Devresse","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"12","key":"10.1016\/j.lpm.2021.104063_bib0490","doi-asserted-by":"crossref","first-page":"4398","DOI":"10.1093\/ndt\/gfs317","article-title":"Prognosis of scleroderma renal crisis: a long-term observational study","volume":"27","author":"Cozzi","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.lpm.2021.104063_bib0495","article-title":"Canadian Scleroderma Research Group. Mammalian target of rapamycin (mTOR) is activated in the kidneys of patients with scleroderma renal crisis","author":"Salituri","year":"2019","journal-title":"J Scleroderma Related Disorders"},{"issue":"4","key":"10.1016\/j.lpm.2021.104063_bib0500","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1053\/j.ajkd.2009.02.015","article-title":"Endothelin receptor antagonism and renin inhibition as treatment options for scleroderma kidney","volume":"54","author":"Dhaun","year":"2009","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"10.1016\/j.lpm.2021.104063_bib0505","first-page":"1198","article-title":"Recurrence of Scleroderma Renal Crisis in Transplanted Kidney Leading to Graft Failure","volume":"43","author":"Wierzbicki","year":"2016","journal-title":"J Rheumatol"},{"issue":"4","key":"10.1016\/j.lpm.2021.104063_bib0510","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/1529-0131(199904)42:4<763::AID-ANR21>3.0.CO;2-V","article-title":"Fertility and pregnancy outcome in women with systemic sclerosis","volume":"42","author":"Steen","year":"1999","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.lpm.2021.104063_bib0515","first-page":"15","article-title":"Pregnancy in women with systemic sclerosis","volume":"94","author":"Steen","year":"1999","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.lpm.2021.104063_bib0520","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.rdc.2007.03.001","article-title":"Pregnancy in scleroderma","volume":"33","author":"Steen","year":"2007","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.lpm.2021.104063_bib0525","first-page":"S45","article-title":"Management of pregnancy in scleroderma renal crisis","volume":"52","author":"Steen","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.lpm.2021.104063_bib0530","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/art.41191","article-title":"2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases","volume":"72","author":"Sammaritano","year":"2020","journal-title":"Arthritis Rheumatol"},{"issue":"8","key":"10.1016\/j.lpm.2021.104063_bib0535","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1136\/annrheumdis-2016-209909","article-title":"Update of EULAR recommendations for the treatment of systemic sclerosis","volume":"76","author":"Kowal-Bielecka","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.lpm.2021.104063_bib0540","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1097\/BOR.0b013e3283108df7","article-title":"Diagnosis, management and prevention of scleroderma renal disease","volume":"20","author":"Penn","year":"2008","journal-title":"Curr Opin Rheumatol"},{"issue":"2","key":"10.1016\/j.lpm.2021.104063_bib0545","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/nrneph.2009.228","article-title":"Aldosterone \u201cescape\u201d vs \u201cbreakthrough\u201d","volume":"6","author":"Schrier","year":"2010","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.lpm.2021.104063_bib0550","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1136\/annrheumdis-2015-eular.3605","article-title":"Development of a \u201cRenal Crisis Prevention Card\u201d as an Education Tool to Improve Outcomes in High Risk Patients with Systemic Sclerosis","volume":"74","author":"Shapiro","year":"2015","journal-title":"Ann the Rheum Dis"}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498221000026?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498221000026?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:06:51Z","timestamp":1760105211000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0755498221000026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S0755498221000026"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2021.104063","relation":{},"ISSN":["0755-4982"],"issn-type":[{"value":"0755-4982","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Scleroderma renal crisis","name":"articletitle","label":"Article Title"},{"value":"La Presse M\u00e9dicale","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lpm.2021.104063","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104063"}}